Earth Science Tech reported its second fiscal quarter ended September 30, 2025, with revenue rising 6.24% year‑over‑year to $9.05 million and net profit increasing 18.48% to $0.94 million. Total assets grew 71.64% to $8.66 million, while the company reduced its common share count by 3.57% to 292.8 million shares, a move that supports shareholder value through an ongoing share‑repurchase program.
Revenue growth was modest but steady, reflecting continued demand in the company’s core operating businesses. The compounding pharmacy and telemedicine platforms, bolstered by recent acquisitions of Las Villas Health Care, DOConsultations, and Magnefuse, contributed the bulk of the $0.56 million increase. The mix shift toward higher‑margin services helped offset the modest rise in operating expenses.
The 71.64% jump in total assets is largely attributable to the acquisition strategy that has been a cornerstone of Earth Science Tech’s growth plan. The newly acquired entities added $3.62 million in assets, while organic expansion of existing operations added another $1.04 million. This asset base expansion underpins the company’s ability to scale its high‑potential businesses and supports future revenue growth.
The share‑count reduction of 3.57% reflects the company’s commitment to returning capital to investors. The repurchase program, recently increased to $10 million and extended through 2027, has been a key tool for managing the capital structure and enhancing earnings per share.
Gross profit rose 7.3% to $6.72 million, maintaining a gross margin of roughly 74% for the quarter. The margin stability is a result of disciplined cost control and a favorable mix of high‑margin services, even as the company invests in integration and scaling of its newly acquired businesses. Net profit growth outpaced revenue growth, driven by the combination of margin maintenance and the share‑repurchase program’s impact on earnings per share.
CEO Giorgio R. Saumat highlighted the quarter as evidence of successful execution of the company’s strategy to scale high‑potential businesses. He noted that the 71% year‑over‑year growth in total assets and the 22.65% increase in assets since the March year‑end are direct measures of the company’s focus on fundamental growth and shareholder value. The company remains confident in its acquisition pipeline and operational integration plans, with no significant challenges reported for the quarter.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.